Skip to main content

Table 1 Myo-Inositol levels in 158JP oligodendrocytes, PMD fibroblasts and PMD lymphocytes

From: Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction

Cells

Myo-Inositol (-fold control)

158JP oligodendrocytes

8.7 ± 0.78

PMD Fibroblasts

6.8 ± 0.55

PMD Lymphocytes

1.9 ± 0.10

  1. N = 5 (repeated 3 times); all increases are significant (p < 0.01)